{"podcast":{"title":"Metabolic Mind","slug":"metabolic-mind-6253550","podcast_index_feed_id":6253550,"rss_url":"https://feeds.captivate.fm/metabolic-mind/","website_url":"https://metabolicmind.org/","image_url":"https://artwork.captivate.fm/d5c870fb-4d35-464f-8bde-33ce9e2b58c4/MM-Podcast-cover-final.png","author":"Bret Scher","episode_count":253,"summary":"Metabolic Mind is working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. Metabolic interventions like ketogenic therapy are being used to treat serious mental illnesses like Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. We explore topics that can help you understand how Metabolic Psychiatry might help you or a loved one treat mental disorders Watch our videos at https://www.youtube.com/@metabolicmind Our channel is for information only. Consult your physician before changing your lifestyle or medications.","last_synced_at":"2026-09-29T14:20:16.643659+00:00","page_url":"https://stenobird.com/podcast/metabolic-mind-6253550"},"episode":{"title":"BITESIZE: New Study: Could GLP-1 Medications Be Reducing Physical Activity?","slug":"bitesize-new-study-could-glp-1-medications-be-reducing-physical-activity","published_at":"2026-07-30T12:00:00+00:00","page_url":"https://stenobird.com/podcast/metabolic-mind-6253550/bitesize-new-study-could-glp-1-medications-be-reducing-physical-activity","show_page_url":"https://stenobird.com/podcast/metabolic-mind-6253550","url":"https://metabolicmind.org/","audio_url":"https://episodes.captivate.fm/episode/a2242ab3-8858-4522-8a3f-c302aa7280df.mp3","summary":"Do GLP-1 medications like Ozempic reduce physical activity? Preliminary research suggests they might, raising important questions about how exercise should be supported alongside treatment. GLP-1 medications are helping many people achieve meaningful weight loss and metabolic improvements. At the same time, findings presented at the Endocrine Society’s annual meeting showed declines in daily steps and moderate-to-vigorous activity after treatment began. In this video, Dr. Bret Scher examines those results, explores why activity levels may fall, and explains how similar concerns can arise with medications such as statins and antipsychotics. He covers: What the study found about physical activity Why side effects and rapid weight loss may reduce movement How muscle loss can affect long-term metabolic health Why resistance training and protein intake matter How clinicians can provide more structured exercise support These findings highlight the importance of pairing GLP-1 medications with proactive support for physical activity and muscle preservation. More broadly, they suggest that when a treatment can affect appetite, energy, or body composition, those effects should be monitored and addressed as part of ongoing care. 👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/ 🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode. #MetabolicMind #KetogenicTherapy #GLP1 Expert Featured: Bret Scher, MD - Baszucki Group Medical Director & Host of the Metabolic Mind Podcast https://www.linkedin.com/in/bret-scher-08baaa102/ https://www.instag…","meta_description":"Do GLP-1 medications like Ozempic reduce physical activity? Preliminary research suggests they might, raising important questions about how exercise shoul…","key_points":[],"chapters":[],"topics":[],"duration_seconds":447,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/metabolic-mind-6253550/episodes/bitesize-new-study-could-glp-1-medications-be-reducing-physical-activity/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/metabolic-mind-6253550/bitesize-new-study-could-glp-1-medications-be-reducing-physical-activity.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}